Major R&D Pipeline: 3ADCs slide image

Major R&D Pipeline: 3ADCs

Profit Attributable to Owners of the Company Increased by 3.4 Bn JPY Daiichi-Sankyo (Bn JPY) Other Revenue/Expenses -2.0 (Profit increased) FY2020 Results 31.9 FY2021: Gains related to sale of Osaka logistics center -2.1 Core Operating 9.6 Financial Income/Expenses etc. +6.0 (Profit Decreased) Profit Other Revenue/ Expenses Financial Income/ Expenses etc. 2.0 FY2020: Financial income due to decrease in contingent consideration of Ambit/quizartinib acquisition Deterioration in forex gains/losses +4.7 +0.6 6.0 Income Taxes etc. +2.3 (Profit Decreased) FY2020 Q1 FY2021 Q1 YOY Income Taxes etc. 2.3 Profit before Tax Income Taxes etc. 41.4 47.1 +5.7 9.6 11.8 +2.3 FY2021 Results 35.2 Tax rate 23.1% 25.2% +2.1% Positive Factors Negative Factors 7
View entire presentation